Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, sits down with Nichole Montgomery, Shannon O’Shea, and Phil Sclafani to unpack the sweeping implications of the newly signed One Big Beautiful Bill Act (OBBBA). With nearly a third of the bill dedicated to healthcare, the team explores how this landmark legislation will reshape coverage, funding, and delivery across the payer, provider, and pharma landscape.

Discussion highlights:

The OBBBA introduces new work requirements and eligibility rules that could lead to coverage loss for over 13 million people, placing new burdens on payers and states
Providers face increased uncompensated care, especially in rural areas, with added administrative complexity and a push toward technology and alternative care models
Payers are bracing for membership loss, reduced Medicaid funding, and increased administrative load as new eligibility rules take effect
Pharma may see reduced demand from public programs but gains through an orphan drug exemption and incentives for domestic manufacturing
The bill’s sweeping changes will disrupt healthcare, but with foresight, organizations can model financial impact, prepare for operational disruption, and plan strategic responses

Speakers:

Glenn Hunzinger (host), Health Industries Leader, PwC
Shannon O'Shea, Principal, Health Transformation, Provider Clinical Transformation, PwC
Phil Scalfani, Principal, Customer Transformation, Pharmaceutical & Life Sciences, PwC
Nichole Montgomery, Principal, Health Transformation, Health Services, PwC

Linked Materials:

https://www.pwc.com/us/en/industries/health-industries/library/impact-of-obbba-on-us-health-system.html

https://www.pwc.com/us/en/industries/health-industries/health-policy-and-intelligence-institute.html

For more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.